Location History:
- Baltimore, MD (US) (2013)
- Charlottesville, VA (US) (2015 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Barbara Dziegielewska: Innovator in Cancer Treatment
Introduction
Barbara Dziegielewska is a prominent inventor based in Charlottesville, VA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of compounds that inhibit human DNA ligases. With a total of 3 patents, her work has the potential to impact cancer therapies significantly.
Latest Patents
Dziegielewska's latest patents focus on compounds that inhibit human DNA ligases and methods for treating cancer. These patents include methods for treating cancer using these compounds, as well as techniques for providing insights into the reaction mechanisms of human DNA ligases. Her work aims to identify the specific human DNA ligase involved in various DNA repair pathways. Additionally, she has developed screening methods for these compounds, further advancing the understanding of their applications in cancer treatment.
Career Highlights
Throughout her career, Barbara Dziegielewska has worked with esteemed institutions, including the University System of Maryland and Stc.unm. Her research has garnered attention for its innovative approach to tackling cancer at the molecular level. Dziegielewska's dedication to her work has positioned her as a leading figure in her field.
Collaborations
Some of her notable collaborators include Alan Edward Tomkinson and Alexander D MacKerell, Jr. Their combined expertise has contributed to the advancement of research in DNA ligases and cancer treatment.
Conclusion
Barbara Dziegielewska's contributions to cancer research through her innovative patents and collaborations highlight her as a key inventor in the field. Her work continues to pave the way for new therapeutic strategies in cancer treatment.